AbbVie, Inc.
(NYSE : ABBV)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Do You Like Swing Trading?
Learn how we win with easy 3-5 day holds.
Be 'active' in the market while NOT being tied to your desk.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Major
symbolcompany%chnglast%shortavg$volume
JNJJohnson & Johnson 1.53%147.900.7%$946.54m
PFEPfizer Inc. 1.05%36.430.9%$901.32m
MRKMerck & Co., Inc. 0.02%82.950.7%$692.55m
ABBVAbbVie, Inc. 1.57%87.591.9%$687.86m
BMYBristol-Myers Squibb Co. 0.50%59.791.0%$641.00m
LLYEli Lilly & Co. -0.95%148.841.1%$556.47m
AZNAstraZeneca Plc -1.31%54.791.2%$254.39m
NVSNovartis AG 0.06%87.160.2%$163.98m
GSKGlaxoSmithKline Plc 0.13%37.850.2%$109.32m
PRNBPrincipia Biopharma, Inc. 0.00%100.050.0%$86.76m
NVONovo Nordisk A/S 0.19%69.190.1%$57.77m
RGENRepligen Corp. 1.63%146.667.1%$50.35m
SNYSanofi 0.37%50.970.2%$49.18m
RPRXRoyalty Pharma Plc 2.15%40.930.2%$48.02m
OPKOPKO Health, Inc. -1.28%3.1811.2%$43.02m

Company Profile

AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology, and dermatology; oncology, including blood cancers; virology, including hepatitis C virus (HCV) and human immunodeficiency virus (HIV); neurological disorders, such as Parkinson's disease; metabolic diseases, comprising thyroid disease and complications associated with cystic fibrosis; pain associated with endometriosis; and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL.